Recursion Pharmaceuticals (RXRX) Shares Fall Over 4% Premarket After $200M Equity Offering Announcement
· gurufocus.com
On October 15, 2026, Recursion Pharmaceuticals Inc (NASDAQ: RXRX) saw its shares decline more than 4% in premarket trading following the announcement of a $200
On October 15, 2026, Recursion Pharmaceuticals Inc (NASDAQ: RXRX) saw its shares decline more than 4% in premarket trading following the announcement of a $200 ...